In the BioHarmony Drug Report Database
Irbesartan
Avapro, Aprovel, Irbesartan Winthrop, Irbesartan Zentiva, Karvea (irbesartan) is a small molecule pharmaceutical. Irbesartan was first approved as Avapro on 1997-08-26. It is used to treat diabetic nephropathies, hypertension, and left ventricular dysfunction in the USA. It has been approved in Europe to treat hypertension. It is known to target sodium/bile acid cotransporter and type-1 angiotensin II receptor.
Trade Name
|
Aprovel, Irbesartan Winthrop, Irbesartan Zentiva, Karvea |
|---|---|
Common Name
|
irbesartan |
ChEMBL ID
|
CHEMBL1513 |
Indication
|
diabetic nephropathies, hypertension, left ventricular dysfunction |
Drug Class
|
Angiotensin II receptor antagonists |
Image (chem structure or protein)